Rho(d) Immune Globulin - Neonatal Disorders

Relevant Publications

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).

Issue Release: 2024

Guideline No. 448: Prevention of Rh D Alloimmunization.

Issue Release: 2024

Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation.

Issue Release: 2024

Prenatal Care: An Evidence-Based Approach.

Issue Release: 2023

A Case of Massive Fetal-Maternal Hemorrhage: Lessons Learned in Diagnosis and Treatment.

Issue Release: 2022

RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.

Issue Release: 2020

No. 133-Prevention of Rh Alloimmunization.

Issue Release: 2018

Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine.

Issue Release: 2018

High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.

Issue Release: 2016

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.

Issue Release: 2015

Potential drug interaction between Rho(D) immune globulin and live virus vaccine.

Issue Release: 2014

Update on prenatal care.

Issue Release: 2014

Rituximab for the treatment of acute refractory ITP.

Issue Release: 2014

Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site.

Issue Release: 2012

Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.

Issue Release: 2011

Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.

Issue Release: 2008

Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.

Issue Release: 2008

A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.

Issue Release: 2007

A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.

Issue Release: 2007

A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.

Issue Release: 2007

How Can Pediatric Clinics Improve Workflow?

What Are the Challenges in Antibiotic Stewardship for Neonates?

Why are Family Support Services Important?

How Can Parents and Caregivers Encourage Self-Discovery?

What Are Common Language Developmental Delays?

How is a Feeding Tube Inserted?

What are the Challenges in Providing This Training?

What are the Clinical Signs of Fetal Distress?

How to Prepare for a Neonatal CT Scan?

What are Some Common Behavioral Disorders in Neonates?

Partnered Content Networks

Relevant Topics